Free Trial

AVITA Medical Q3 2024 Earnings Report

AVITA Medical logo
$8.37 +0.05 (+0.60%)
As of 03/11/2025 04:00 PM Eastern

AVITA Medical EPS Results

Actual EPS
-$0.62
Consensus EPS
-$0.41
Beat/Miss
Missed by -$0.21
One Year Ago EPS
-$0.34

AVITA Medical Revenue Results

Actual Revenue
$19.55 million
Expected Revenue
$19.65 million
Beat/Miss
Missed by -$100.00 thousand
YoY Revenue Growth
N/A

AVITA Medical Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Remove Ads

AVITA Medical Earnings Headlines

Avita Medical management to meet with Lake Street
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Avita Medical price target lowered to $22 from $25 at D. Boral Capital
AVITA Medical, Inc. (RCEL): A Bull Case Theory
See More AVITA Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AVITA Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AVITA Medical and other key companies, straight to your email.

About AVITA Medical

AVITA Medical (NASDAQ:RCEL), together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

View AVITA Medical Profile

More Earnings Resources from MarketBeat